WARNING: members of the public are being contacted by people claiming to work for AXA Investment Managers UK Limited.  Find out more information and what to do by clicking here.

AXA IM UK

We actively invest for the long term to help our clients, the communities of the world, and our planet to prosper

Investment Institute

Outlook 2025

Find what our experts believe 2025 has in store for investors

Download the full outlook

The future needs better than business as usual

Our range of investment strategies aim to meet the financial challenges we face today and the environmental and social landscapes of the future.

We actively look for opportunities that will provide long-term investment growth whilst seeking to minimise volatility.

We have a variety of funds to target specific, financial goals for private investors. While Institutional clients can benefit from bespoke consultancy and strategies tailored to their needs.

Strategies

Fixed income carbon transition

Investing in the transition to Net Zero could help reduce climate-related risks and enhance long-term returns.

Discover the strategies
Featured Funds

We integrate ESG into 85% of our investment activities across asset classes.1

Find detailed information on our full range of funds, including performance, prices, and commentary from fund managers.

Fixed Income
Fixed income
AXA Global Short Duration Bond Fund

The aim of the Fund is to provide income combined with any capital growth.

View funds
Fixed Income
AXA Global Strategic Bond Fund

The aim of the Fund is to generate income and growth over the medium term (being a period of five years or more).

View funds
Fixed Income
AXA ACT Carbon Transition Sterling Buy and Maintain Credit Fund

The aim of the Fund is to provide an income and capital return (net of fees) in line with the market for sterling denominated, investment grade bonds issued by companies over the long-term while maintaining a low turnover of bonds held by the Fund.

View funds
Equities
Equities
AXA Framlington Biotech Fund

The AXA Framlington Biotech Fund invests in shares of listed companies, principally in the biotechnology, genomic and medical research industry.

View funds
Equities
AXA Framlington Global Technology Fund

The aim of this Fund is to provide long-term capital growth.

View funds
Equities
AXA Framlington UK Sustainable Equity Fund

The aim of this Fund is to provide long-term capital growth.

View funds
Impact Investing
Impact Investing
AXA WF ACT Green Bonds

To seek both income and growth of your investment, in EUR, and a sustainable investment objective, from an actively managed bonds portfolio contributing to financing of the energy and ecology transition and demonstrating a positive environmental impact.

View funds
Impact Investing
AXA ACT Green Short Duration Bond Fund

The aim of this Fund is: (i) to provide income and capital growth over the medium term (being three years); and (ii) to invest in bonds which finance projects which will generate an environmental benefit, known as 'green bonds'.

View funds
Impact Investing
AXA WF ACT Biodiversity

The Sub-Fund seeks long-term growth of your investment, in USD, from an actively managed listed equity and equity-related securities portfolio, of sustainable investments in issuers acting positively for the biodiversity by reducing or limiting negative impact of human's activities on biodiversity.

View funds

Fraud warning 

Members of the public are being contacted by people claiming to work for AXA Investment Managers UK Limited.  Find out more information and what to do by clicking here.

 

    Disclaimer

    This promotional communication does not constitute on the part of AXA Investment Managers a solicitation or investment, legal or tax advice. This material does not contain sufficient information to support an investment decision.

    Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.

    Risk Warning

    The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested.